Target intelligence / Profile preview

Picornain 3C (3C protease) (3Cpro)

Target
3Cpro
Molecular classification
Enzyme, Cysteine protease, Hydrolase, C3 family peptidase
01

Overview

The 3C protease (3Cpro), formally known as Picornain 3C, is an essential cysteine protease encoded by members of the Picornaviridae family, including Human Rhinovirus (HRV), Enterovirus 71, and Poliovirus (UniProt: P04936). It is responsible for the majority of the proteolytic processing of the viral polyprotein, cleaving it at specific Gln-Gly or Gln-Ser sites to generate mature structural and non-structural proteins necessary for viral replication (PubMed: 15155836). In addition to polyprotein processing, 3Cpro acts as a virulence factor by cleaving host cell proteins such as TATA-binding protein (TBP) and transcription factor IIIC, effectively shutting down host transcription and blunting the innate immune response (PubMed: 11466373). Because the substrate specificity of 3Cpro is distinct from human cellular proteases, it is considered a highly attractive target for antiviral therapy. Drugs like rupintrivir have been developed as irreversible peptidomimetic inhibitors to block the catalytic cysteine (Cys147 in HRV), though clinical challenges include delivery and the rapid development of viral resistance (PubMed: 12615902). While similar in function and fold to the 3C-like protease (3CLpro) of coronaviruses, Picornain 3C represents a distinct family of enzymes primarily associated with respiratory and enteric picornaviral diseases.

Other names
3C proteaseViral 3C proteasePicornavirus 3C proteaseHuman rhinovirus 3C proteaseEnterovirus 3C protease3C cysteine proteasePolypeptide 3C
02

Mechanism of action

Irreversible or reversible inhibition of the catalytic cysteine residue within the enzyme's active site, preventing the cleavage of the viral polyprotein and subsequent viral replication (PubMed: 11466373).

03

Biological functions

Viral polyprotein processingHost cell transcription inhibitionHost cell translation inhibitionViral RNA bindingInnate immune evasion
04

Disease associations

InfectionCommon coldHand-foot-and-mouth diseasePoliomyelitisViral myocarditisAseptic meningitis
05

Safety considerations

Rapid emergence of drug-resistant viral mutations in the 3C geneLow oral bioavailability of peptidomimetic inhibitorsPotential off-target inhibition of host cysteine proteasesNarrow therapeutic window for acute viral infections
06

Interacting drugs

Rupintrivir (AG7088)

3 more in the full profile.

07

Biomarkers

Viral RNA titerVP1 capsid protein levelsInterleukin-8 (IL-8) levelsHost protein cleavage fragments (e.g., TBP cleavage)

Beyond the preview

Go deeper on Picornain 3C (3C protease) (3Cpro).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Picornain 3C (3C protease) (3Cpro).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call